Search - tctmd.com

Displaying 61 - 80 of 401

Sort: Relevancy | Date

Presentation TCT 2022

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

Presenter: Michael Rinaldi

September 18, 2022

Presentation TCT 2022

TEER in PMR: Current Technical Challenges, Anatomic Limitations, and Clinical Considerations

Presenter: Jason Rogers

September 18, 2022

Presentation TCT 2022

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

TCT 618: Turning the Tide with a Plug in the Hole: Successful transcatheter closure of post-infarct ventricular septal rupture in the context of myocardial infarction without obstructive coronary artery (MINOCA)

Presenter: Muthanna Abdul Halim

September 18, 2022

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Presenter: Linda Gillam

September 18, 2022

Presentation TCT 2022

Insights from the CLASP IID Registry

Presenter: Jörg Hausleiter

September 18, 2022

Presentation TCT 2022

A Thoughtful Cardiologist Viewpoint

Presenter: Allan Schwartz

September 18, 2022

Presentation TCT 2022

An Elite Surgeon’s Perspective

Presenter: Vinay Badhwar

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

ENCIRCLE Trial (M3)

Presenter: David Daniels

September 18, 2022

Presentation TCT 2022

APOLLO Trial (Intrepid)

Presenter: Martin B. Leon

September 18, 2022

Presentation TCT 2022

SUMMIT Trial (Tendyne)

Presenter: Jason H. Rogers

September 18, 2022

Presentation TCT 2022

Iatrogenic Atrial Septal Defects: Imaging and Physiologic Indications for Closure

Presenter: Torsten Vahl

September 18, 2022

Presentation TCT 2022

LVOT Obstruction: Prediction Models and Emerging Prevention Techniques

Presenter: Mayra Guerrero

September 18, 2022

Presentation TCT 2022

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Presenter: Robert Hawkins

September 18, 2022

Presentation TCT 2022

TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0?

Presenter: Juan F. Granada

September 18, 2022

Presentation TCT 2022

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

Presenter: Gordon Wong

September 18, 2022

Presentation TCT 2022

A Completely Biological Engineered Tissue Valve for Transcatheter Heart Valve Applications (Vascudyne)

Presenter: Zeeshan Hayder Syedain

September 18, 2022

Presentation TCT 2022

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

Presenter: Susheel K. Kodali

September 18, 2022

Advertisement

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

TEER in PMR: Current Technical Challenges, Anatomic Limitations, and Clinical Considerations

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

TCT 618: Turning the Tide with a Plug in the Hole: Successful transcatheter closure of post-infarct ventricular septal rupture in the context of myocardial infarction without obstructive coronary artery (MINOCA)

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Insights from the CLASP IID Registry

A Thoughtful Cardiologist Viewpoint

An Elite Surgeon’s Perspective

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

ENCIRCLE Trial (M3)

APOLLO Trial (Intrepid)

SUMMIT Trial (Tendyne)

Iatrogenic Atrial Septal Defects: Imaging and Physiologic Indications for Closure

LVOT Obstruction: Prediction Models and Emerging Prevention Techniques

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0?

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

A Completely Biological Engineered Tissue Valve for Transcatheter Heart Valve Applications (Vascudyne)

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content